INVO Bioscience Acquires NAYA Biosciences in All-Stock Merger

The9 Limited’s Investee Nanyang Biologics Advances Planned Nasdaq Listing in US$1.5 Billion Business Combination

August 11, 2026

AI & Machine Learning

The9 Limited said its Singapore investee Nanyang Biologics Pte. Ltd. (NYB) received notice of effectiveness from the U.S. SEC for its Form F-4 registration statement tied to a previously announced business combination valued at about US$1.5 billion. The listing is planned on Nasdaq (ticker symbol “NYB”), subject to NYB’s SPAC extraordinary general meeting and Nasdaq approval.

Yarrow Bioscience Completes Merger with VYNE Therapeutics

July 27, 2026

Biotechnology

Yarrow Bioscience announced the completion of its merger with VYNE Therapeutics, with the combined company operating as Yarrow Bioscience, Inc. The transaction follows previously announced private financings totaling approximately $200 million and includes the initiation of dosing in a Phase 2a/2b trial of YB-101 for Graves' disease and thyroid eye disease.

USANA Health Sciences Acquires 78.8% Stake in Hiya Health

December 23, 2024

Consumer Products

USANA Health Sciences acquired a 78.8% controlling stake in Hiya Health Products, LLC for approximately $205 million in cash, closing December 23, 2024. The acquisition expands USANA's direct-to-consumer presence in the children's health and wellness market and is expected to be accretive to USANA's 2025 adjusted EBITDA.

INVO Bioscience Acquires Wisconsin Fertility Institute

March 20, 2023

Healthcare Services

INVO Bioscience, Inc. (Nasdaq: INVO) has signed binding agreements to acquire Wisconsin Fertility Institute, a Madison-area fertility clinic that generated approximately $5.5 million in trailing 12-month revenue. The purchase price is $10.0 million payable over three years, and the clinic will become a wholly owned subsidiary to expand INVO's clinic footprint and support adoption of its INVOcell technology.

Asahi Kasei Medical to Acquire Bionova Scientific

April 14, 2022

Healthcare Services

Asahi Kasei Medical, through a U.S. subsidiary, has agreed to wholly acquire Bionova Scientific, LLC, a U.S.-based biopharmaceutical CDMO providing contract process development and GMP-compliant contract manufacturing services. The acquisition will add CDMO capabilities to Asahi Kasei Medical’s existing bioprocess business and broaden know-how-driven services for next-generation antibody drugs.

EPAM Systems Acquires NAYA Technologies (and US subsidiary NAYA Tech)

November 5, 2019

IT Services

EPAM Systems has acquired NAYA Technologies, an Israel-headquartered consultancy, and its US subsidiary NAYA Tech (San Jose, CA) to strengthen EPAM's cloud migration, data management and database migration capabilities, including the migVisor automated migration assessment tool. The acquisition augments EPAM's technology consulting practice and accelerates its ability to deliver end-to-end cloud and data services to enterprise clients.